2385 Soiken Holdings
- 167
- -1-0.60%
Soiken Holdings News
Soiken Holdings: Confirmation
Soiken Holdings: Quarterly Report - 30th Term 3rd Quarter (2024/01/01 - 2024/03/31)
Soiken Holdings: Summary of Financial Results for the 3rd Quarter Ending 2024/6 [Japanese GAAP] (Consolidated)
Taiseiken, Obayashi Corporation, Toray, Shiono Yoshi (13th) (1417-5070)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/13 (Mon) ＜1417＞Miraite One ＜1435＞Robohome＜146A＞Colombia ＜1515＞Nippon Steel Mining ＜1518＞Mitsui Matsushima HD ＜1663＞K&O Energy＜167A＞Ryosan Ryoyo ＜1736＞Autech ＜174
Front market [stocks that have moved, stocks that have been created]
*Renova ＜9519＞ 1431 +193 capital and business alliance with Tokyo Gas is highly appreciated. *Japan Electronics ＜6951＞ 6897 +735 Goldman Sachs Securities upgraded investment decisions. *KOKUSAI ELECTRI ＜6525＞ 4475 +350 meters semiconductor stock appreciation concentrated on semiconductor-related purchases. *Shibaura Mechatronics ＜6590＞ 6600 +470 semiconductor stock appreciation led to a strong buying advantage. *Tatsumo ＜6266＞ 4145 +270 m semiconductor
Stocks that moved the day before part 1 regional newspapers, TORICO, Omron, etc.
<コード>Stock name 1-day closing price ⇒ Claudia ＜3607＞ 445 +22 first half operating income increased 30.2% compared to the previous day. Mitachi ＜3321＞ 1143-92 cumulative operating profit for the 3rd quarter decreased by 41.9%. Energy Change ＜4169＞ submitted an application for approval to extend the deadline for submitting securities reports for the fiscal year ending 585-10023/12. Regional newspaper company ＜2164＞ 631 +10024 turned into an operating surplus in the first half of the fiscal year ending 2014/8. General Medical Research Holdings＜2385＞ 191 +29 East
The Tokyo Stock Exchange Growth Index fell and went back to a soft trend again without being able to return
TSE Growth Market Index 924.39 -13.65 /volume 12,560 shares/trading price 169.8 billion yen TSE growth market 250 index 734.62 -11.83 /turnover 70.94 million shares/trading price 88.7 billion yen Today's growth market fell into both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks is 162, the number of falling stocks is 386, and 24 unchanged. The US market on March 29th is closed on the Good Friday (Good Friday) holiday
Backstage [stocks that moved, stocks that were made]
*Claudia ＜3607＞ 445 +22 first half operating profit increased by 30.2%. *Mitachi ＜3321＞ 1143-92 cumulative operating profit for the 3rd quarter decreased by 41.9%. *Energy Change ＜4169＞ 585 - Submit an application for approval to extend the deadline for submitting securities reports for the fiscal year ending 10023/12. *Regional newspaper company ＜2164＞ 631 +10024 turned into an operating surplus in the first half of the fiscal year ending 2014/8. *General Medical Research Holdings＜2385＞ 191 +29 Obstetrics and Sciences at the Jikei University School of Medicine
Emerging Market Stock Digest: Energy Change Stop-Low, TORICO Stop-High
＜4169＞ ENECHANGE 585 -100 stops cheaper. It has been announced that an approval application relating to the extension of the submission deadline for securities reports for the fiscal year ending 23/12 will be submitted to the Kanto Finance Bureau. The submission deadline before the extension is 4/1, and if the extension is approved, the submission deadline is 6/28. This is because it is expected that it will take time for investigations related to accounting processing related to the SPC scheme for the EV charging business disclosed on March 27, settlement work, and audit procedures to be included in the consolidated scope. Also, the same from the audit firm
Notable stock digest (front field): Sanoyas HD, ERI HD, General Medical Research Institute, etc.
Mitachi ＜3321＞: 1149 yen (-86 yen) fell sharply. The third quarter financial results were announced last weekend. Cumulative operating income was 1.29 billion yen, down 41.9% from the same period last year, and the 12-2 fiscal year was 360 million yen, down 37.5% from the same period, so it looks like the drastic decline trend will continue. Domestically, orders have declined in the industrial equipment field and amusement field, and overseas orders also seem to have declined in the EMS, semiconductor/electronic parts, and industrial equipment fields due to sluggish investment in China. The current stock price is in the high range
General Medical Research Institute --- high price since the beginning of the year, an industry-academia collaboration course was opened at the Jikei University School of Medicine, and a joint research agreement was also signed
The price has been high since the beginning of the year. An industry-academia collaboration course “Fatigue Medicine Course” will be established at the Jikei University School of Medicine, and it has been announced that a joint research agreement will be signed with the educational corporation Jikei University. The purpose is social implementation of research results related to fatigue, depression, etc. The course will be set up for 5 years from 4/1 to 29/3/31. Research results expected from joint research include provision of fatigue measurement methods to objectively measure physiological fatigue using saliva and provision of fatigue and resilience measurement methods based on analysis of molecular mechanisms
Is it a steady, wait-and-see development with a strong wait-and-see mood
[Emerging Markets Individual Stock Strategy] Today's emerging markets are likely to be slightly dominated by buying. The major Western markets were closed on 3/29 last weekend, and there are few clues, and it is expected that the wait-and-see mood will intensify in the Tokyo market today. Under these circumstances, the market continues to be aware of a sense of caution against exchange intervention, and export-related stocks of the Tokyo Stock Exchange Prime are in a situation where it is somewhat difficult to handle, and it seems that it is easy for funds to go to emerging markets such as Tokyo Stock Exchange Growth, where there are many domestic demand-type companies. Also, April is in March
Kyom, TORICO, etc.
＜2385＞Establishing an industry-academia collaboration course and signing a joint research agreement with General Medical Research Institute Tokyo Jikei University ＜3557＞Number of shares issued from mass exercise of U&C 9th Stock Acquisition Rights (with exercise price correction clauses) from the 6th, 50,000 shares ＜3998＞Business Alliance with Surara Net Withers ＜9696＞ ＜4583 Kiom CT-701 license agreement terminated with ADC Therapeutics due to the transition of clinical trial subjects to NCI ＜4588＞Oncolis Bio 19th Stock Acquisition Rights (
Soiken Holdings Sees FY Loss Y440.00M
Soiken Holdings Inc. also released the following forecasts: GROUP Year Ending Jun 2024 Revenue Y5.74 bln Operating Profit (Y400.00 mln) Pret
Soiken Holdings Sees FY Net Y180.00M
Soiken Holdings Inc. also released the following forecasts: GROUP Year Ending Jun 2024 Revenue Y6.82 bln Operating Profit Y280.00 mln Pretax Profi
Soiken Holdings 9-Mos Net Y496.00M Vs Net Y640.00M
Soiken Holdings Inc. (2385.TO) Japan Nine Months Ended March 31 GROUP 2023 2022 Revenue Y6.59 bln Y7.09 bln Operating Profit Y784.00 m
Soiken Holdings 1H Net Y209.00M Vs Net Y414.00M
Soiken Holdings Inc. (2385.TO) Japan 1st Half Ended December 31 GROUP 2022 2021 Revenue Y4.22 bln Y5.15 bln Operating Profit Y344.00 m
Soiken Holdings Sees 1H Parent Pretax Y345.00M
PARENT New Forecast Prior For Year to Dec 2022 Forecast Revenue Y4.22 bln N/A Pretax Profit Y345.00 mln N/A Net
Soiken Holdings Sees 1H Net Y350.00M
Soiken Holdings Inc. also released the following forecasts: GROUP 1st Half To Dec 2022 Revenue Y5.00 bln Operating Profit Y500.00 mln Pretax Profi
Analysis
Price Target
No Data
